Dr. Reddy's Laboratories LimitedRDYNYSE
LOADING
|||
Operating Income Performance
Above historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$71.84B
↑ 126% above average
Average (9y)
$31.85B
Historical baseline
Range
High:$71.84B
Low:$431.44M
CAGR
+10.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $71.84B | +6.1% |
| 2024 | $67.73B | +18.5% |
| 2023 | $57.14B | +93.9% |
| 2022 | $29.48B | +6732.0% |
| 2021 | $431.44M | -97.3% |
| 2020 | $15.99B | -23.4% |
| 2019 | $20.89B | +75.3% |
| 2018 | $11.92B | -11.7% |
| 2017 | $13.50B | -54.4% |
| 2016 | $29.62B | - |